Introduction & Welcome

Adjuvant RT following RP for PCa Systematic review and meta analysis

Eight year outcomes of a phase III randomized trial of conventional versus hypofractionated high dose intensity modulated radiotherapy for prostate cancer

FINAL OVERALL SURVIVAL FROM PROSPER

ASCO 2020 Final survival Results from SPARTAN

ARAMIS Final Analysis OS with Darolutamide Plus ADT vs Placebo Plus ADT

Radical Prostatectomy for patients with High risk Very high Risk or Metastatic Prostate Cancer

Adjuvant docetaxel after definitive radiotherapy for high risk prostate cancer

Panel discussion - Non metastatic Prostate cancer

THE PROfound trial Lynparza in HRRm mCRPC

ARCHES A Randomized PhaseIII Study of Androgen Deprivation Therapy with Enzalutamide or Placebo in Men with Metastatic Hormone Sensitive Prostate cancer

Addition of docetaxel to hormonal therapy in Low and high burden mestatic hormone

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Optimal seqencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration resistant prostate Cancer

TheraP a randomized phase 2 trial of 177lu PSMA 617 theranostic treatment vs cabazitaxel in progressive metastatic castration resistant prostate cancer

Pain response & health related quality of life analysis

Panel Discussion - PROSTATE CANCER PANVELL

Is Age just a Number

Closing remarks